What is he best known for?
The fields of study he is best known for:
Yuichi Shiraishi mostly deals with Mutation, Genetics, Leukemia, Myeloid and Cancer research.
His Mutation study incorporates themes from Cancer, NPM1 and Molecular biology.
The study incorporates disciplines such as Germline mutation, Myeloid leukemia, Epigenetics and Myelodysplastic syndromes in addition to Leukemia.
The Myelodysplastic syndromes study combines topics in areas such as Proportional hazards model, Oncology and Somatic evolution in cancer.
Myeloid is a subfield of Immunology that Yuichi Shiraishi studies.
His Cancer research research is multidisciplinary, incorporating perspectives in T-cell lymphoma, Lymphoma, T cell, CTCF and Exome.
His most cited work include:
- Frequent pathway mutations of splicing machinery in myelodysplasia (1387 citations)
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes (791 citations)
- Integrated molecular analysis of clear-cell renal cell carcinoma. (640 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Genetics, Cancer research, Mutation, Exome sequencing and Gene.
His research on Genetics often connects related topics like Myeloid.
Yuichi Shiraishi interconnects Leukemia and Myelodysplastic syndromes in the investigation of issues within Myeloid.
His research in Cancer research intersects with topics in Somatic cell, Carcinogenesis, T cell, KRAS and Lymphoma.
His Mutation study integrates concerns from other disciplines, such as Molecular biology and Cancer, Internal medicine.
His Exome sequencing study combines topics in areas such as Frameshift mutation, Deep sequencing, Somatic evolution in cancer, Neuroblastoma RAS viral oncogene homolog and Massive parallel sequencing.
He most often published in these fields:
- Genetics (38.04%)
- Cancer research (28.53%)
- Mutation (23.34%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (28.53%)
- Gene (19.88%)
- Internal medicine (17.58%)
In recent papers he was focusing on the following fields of study:
Yuichi Shiraishi mainly investigates Cancer research, Gene, Internal medicine, Mutation and Genetics.
He combines subjects such as Exome sequencing, Downregulation and upregulation, Myeloproliferative disease, Clone and Leukemia with his study of Cancer research.
His research investigates the connection between Exome sequencing and topics such as Somatic evolution in cancer that intersect with problems in Germline mutation.
His work carried out in the field of Leukemia brings together such families of science as Myeloid, Hematopoietic stem cell transplantation, Myeloid leukemia and Bone marrow.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Oncology and Gene mutation.
His Mutation research includes themes of Biopsy and Haematopoiesis, Stem cell.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Age-related remodelling of oesophageal epithelia by mutated cancer drivers (192 citations)
- Genomic basis for RNA alterations in cancer (92 citations)
In his most recent research, the most cited papers focused on:
Yuichi Shiraishi mainly focuses on Genetics, Exome sequencing, Cancer research, Mutation and Gene.
Many of his studies involve connections with topics such as Myeloid and Genetics.
Yuichi Shiraishi has researched Exome sequencing in several fields, including KRAS, Leukemia, Allele and Deep sequencing.
The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Downregulation and upregulation, Epstein–Barr virus, Clone and Lymphoma.
His study of Exome is a part of Mutation.
His Gene research is multidisciplinary, relying on both Cancer and Physiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
